These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 37493986)
21. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts. Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724 [TBL] [Abstract][Full Text] [Related]
22. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma. Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019 [TBL] [Abstract][Full Text] [Related]
23. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284 [TBL] [Abstract][Full Text] [Related]
24. Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patients. Annunzio K; Bhatta S; Hanel W; Zhao Q; Owen M; Rosen H; Voorhees TJ; Bond DA; Sawalha Y; Sigmund AM; Alinari L; Baiocchi RA; Maddocks KJ; Jones D; Christian B; Epperla N Hematol Oncol; 2024 May; 42(3):e3278. PubMed ID: 38726682 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis. Gao F; Zhang T; Liu H; Li W; Liu X; Qiu L; Li L; Zhou S; Qian Z; Dong S; Zhao S; Wang X; Zhang H Ann Hematol; 2022 Nov; 101(11):2383-2392. PubMed ID: 36029326 [TBL] [Abstract][Full Text] [Related]
26. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225 [TBL] [Abstract][Full Text] [Related]
27. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239 [TBL] [Abstract][Full Text] [Related]
28. [Clinical Features of Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma]. Zhang XL; Yu WJ; Zhu YN; Yang CM; Xiao F; Mai WY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1772-1778. PubMed ID: 36476902 [TBL] [Abstract][Full Text] [Related]
31. External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse. Boyne DJ; Chua N; Owen C; Joe-Uzuegbu O; Shakir H; Gogna P; Jarada TN; Brenner DR; Elia-Pacitti J; Ewara EM; Cheung WY Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e277-e285. PubMed ID: 37331847 [TBL] [Abstract][Full Text] [Related]
32. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. Liu L; Yu X; Li Z; He X; Zha J; Lin Z; Hong Y; Zheng H; Lai Q; Ding K; Jia X; Fu G; Yu H; Yang H; Li Z; Young KH; Xu B J Hematol Oncol; 2022 Aug; 15(1):115. PubMed ID: 35996180 [TBL] [Abstract][Full Text] [Related]
33. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation. Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139 [TBL] [Abstract][Full Text] [Related]
34. Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement. Carreras J; Ikoma H; Kikuti YY; Miyaoka M; Hiraiwa S; Tomita S; Kondo Y; Ito A; Nagase S; Miura H; Kawada H; Roncador G; Campo E; Hamoudi R; Nakamura N Virchows Arch; 2024 Apr; 484(4):657-676. PubMed ID: 38462571 [TBL] [Abstract][Full Text] [Related]
35. Digital and manual interfollicular Ki-67 are associated with a progression-free survival in patients with low-grade follicular lymphoma. Nasir A; Hegerova L; Yousaf H; Forster CL; Shanley R; Linden MA; Bachanova V; Yohe S Am J Clin Pathol; 2024 Apr; 161(4):380-387. PubMed ID: 38044670 [TBL] [Abstract][Full Text] [Related]
36. Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma. Xue LG; Shen HR; Gao R; Du KX; Xing TY; Wang WT; Wang L; Li JY; Liang JH; Xu W Ann Hematol; 2023 Apr; 102(4):851-862. PubMed ID: 36735075 [TBL] [Abstract][Full Text] [Related]
37. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy. Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595 [TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics and survival analysis of Ying ZT; Feng HY; Mi L; Song YQ; Wang XP; Zheng W; Lin NJ; Tu MF; Xie Y; Ping LY; Zhang C; Liu WP; Deng LJ; Zhu J Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):745-750. PubMed ID: 30369186 [No Abstract] [Full Text] [Related]
39. Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016. Qu X; Li H; Braziel RM; Passerini V; Rimsza LM; Hsi ED; Leonard JP; Smith SM; Kridel R; Press O; Weigert O; LeBlanc M; Friedberg JW; Fang M Blood; 2019 Jan; 133(1):81-93. PubMed ID: 30446494 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Montoto S; López-Guillermo A; Altés A; Perea G; Ferrer A; Camós M; Villela L; Bosch F; Esteve J; Cervantes F; Bladé J; Nomdedeu B; Campo E; Sierra J; Montserrat E Ann Oncol; 2004 Oct; 15(10):1484-9. PubMed ID: 15367408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]